Thiobarbiturate-induced histamine release in human skin mast cells

Area of Science:

• Pharmacology
• Immunology
• Dermatology

Background:

• Mast cells are key players in allergic reactions, releasing histamine.
• Certain anesthetic agents can trigger mast cell degranulation.
• Understanding drug-induced histamine release is crucial for patient safety.

Purpose of the Study:

• To investigate the histamine-releasing potential of four barbiturates: thiopental, thiamylal, methohexital, and pentobarbital.
• To compare the effects of these agents on human skin mast cells in vitro.
• To identify potential anesthetic agents suitable for patients with histamine sensitivity.

Main Methods:

• Human skin mast cell preparations were incubated with varying concentrations (10(-5) M to 10(-3) M) of thiopental, thiamylal, methohexital, and pentobarbital.
• Histamine release was quantified.
• Lactic dehydrogenase (LDH) leakage was measured to assess cell viability.

Main Results:

• Thiopental and thiamylal induced a dose-related release of histamine.
• Thiamylal demonstrated a significantly greater histamine release effect compared to thiopental (P < 0.05).
• Pentobarbital and methohexital did not cause significant histamine release at any tested concentration. Histamine release by thiopental and thiamylal was not associated with LDH leakage, indicating minimal cytotoxicity.

Conclusions:

• Thiopental and thiamylal are capable of inducing histamine release from human skin mast cells.
• Methohexital and pentobarbital appear to be non-histamine-releasing agents in this in vitro model.
• Methohexital may be a preferred anesthetic induction agent for patients with heightened histamine sensitivity, such as asthmatics or atopics.